BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30231385)

  • 1. Bones in Multiple Myeloma: Imaging and Therapy.
    Zamagni E; Cavo M; Fakhri B; Vij R; Roodman D
    Am Soc Clin Oncol Educ Book; 2018 May; 38():638-646. PubMed ID: 30231385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging in multiple myeloma: How? When?
    Zamagni E; Tacchetti P; Cavo M
    Blood; 2019 Feb; 133(7):644-651. PubMed ID: 30587527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of multiple myeloma and related plasma cell dyscrasias.
    Walker RC; Brown TL; Jones-Jackson LB; De Blanche L; Bartel T
    J Nucl Med; 2012 Jul; 53(7):1091-101. PubMed ID: 22693310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of Multiple Myeloma.
    Kosmala A; Bley T; Petritsch B
    Rofo; 2019 Sep; 191(9):805-816. PubMed ID: 31185511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future imaging modalities for multiple myeloma and its precursor states.
    Tan E; Weiss BM; Mena E; Korde N; Choyke PL; Landgren O
    Leuk Lymphoma; 2011 Sep; 52(9):1630-40. PubMed ID: 21649546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.
    Pianko MJ; Terpos E; Roodman GD; Divgi CR; Zweegman S; Hillengass J; Lentzsch S
    Clin Cancer Res; 2014 Dec; 20(23):5888-97. PubMed ID: 25294899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
    Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S
    World J Surg Oncol; 2007 Jun; 5():68. PubMed ID: 17584499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM).
    Ippolito D; Besostri V; Bonaffini PA; Rossini F; Di Lelio A; Sironi S
    Eur J Radiol; 2013 Dec; 82(12):2322-7. PubMed ID: 24074647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of imaging in multiple myeloma.
    Baffour FI; Glazebrook KN; Kumar SK; Broski SM
    Am J Hematol; 2020 Aug; 95(8):966-977. PubMed ID: 32350883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there any complimentary role of F-18 NaF PET/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET/CT and F-18 FDG NaF PET/CT.
    Ak İ; Onner H; Akay OM
    Ann Hematol; 2015 Sep; 94(9):1567-75. PubMed ID: 26068066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving role of FDG PET/CT in multiple myeloma imaging and management.
    Agarwal A; Chirindel A; Shah BA; Subramaniam RM
    AJR Am J Roentgenol; 2013 Apr; 200(4):884-90. PubMed ID: 23521465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different lesions revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in patients with multiple myeloma.
    Xu F; Liu F; Pastakia B
    Clin Nucl Med; 2014 Sep; 39(9):e407-9. PubMed ID: 24217536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal Superscan on 18F-FDG PET/CT in a Patient With Multiple Myeloma.
    Fu Z; Chen X; Yang X; Li Q
    Clin Nucl Med; 2019 Feb; 44(2):169-170. PubMed ID: 30516669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.
    Body JJ; Facon T; Coleman RE; Lipton A; Geurs F; Fan M; Holloway D; Peterson MC; Bekker PJ
    Clin Cancer Res; 2006 Feb; 12(4):1221-8. PubMed ID: 16489077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
    Nanni C; Zamagni E; Farsad M; Castellucci P; Tosi P; Cangini D; Salizzoni E; Canini R; Cavo M; Fanti S
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):525-31. PubMed ID: 16453155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.
    Terpos E; Dimopoulos MA; Moulopoulos LA
    Am Soc Clin Oncol Educ Book; 2016; 35():e407-17. PubMed ID: 27249748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of
    Basha MAA; Hamed MAG; Refaat R; AlAzzazy MZ; Bessar MA; Mohamed EM; Ahmed AF; Tantawy HF; Altaher KM; Obaya AA; Afifi AHM
    Jpn J Radiol; 2018 Jun; 36(6):382-393. PubMed ID: 29671193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Imaging techniques in multiple myeloma].
    Ozaki S
    Nihon Rinsho; 2007 Dec; 65(12):2261-7. PubMed ID: 18069271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.